Sale!

RGS9 Gene Bradyopsia Genetic Test

Original price was: $700.Current price is: $500.

-29%

The RGS9 Gene Bradyopsia NGS Genetic DNA Test is a comprehensive genetic analysis designed to detect mutations in the RGS9 gene associated with bradyopsia, a rare inherited retinal disorder affecting visual processing speed. This advanced next-generation sequencing test provides crucial insights for individuals experiencing delayed visual adaptation, difficulty with moving objects, and impaired vision in changing light conditions. The test helps confirm diagnosis, guide treatment decisions, and inform family planning. At only $500 USD, this specialized genetic analysis includes professional genetic counseling to interpret results and understand inheritance patterns. Early detection through this test enables proactive management of vision symptoms and appropriate vision rehabilitation strategies.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

RGS9 Gene Bradyopsia NGS Genetic DNA Test

Understanding RGS9 Gene Bradyopsia Genetic Testing

The RGS9 Gene Bradyopsia NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying mutations in the RGS9 (Regulator of G-protein Signaling 9) gene, which plays a critical role in visual signal transduction. Bradyopsia, meaning “slow vision,” is a rare inherited retinal disorder characterized by delayed visual adaptation and impaired processing of moving objects. This comprehensive genetic analysis utilizes next-generation sequencing technology to provide precise detection of pathogenic variants associated with this condition.

What Does the RGS9 Gene Bradyopsia Test Measure?

This specialized genetic test specifically targets the RGS9 gene, which encodes a protein essential for the rapid termination of phototransduction in retinal photoreceptor cells. The test detects:

  • Pathogenic mutations in the RGS9 gene coding regions
  • Single nucleotide variants (SNVs) affecting protein function
  • Small insertions and deletions (indels) disrupting gene expression
  • Copy number variations impacting gene dosage
  • Regulatory region variants affecting gene regulation

Who Should Consider This Genetic Test?

Clinical Indications and Symptoms

Individuals experiencing the following symptoms should consider the RGS9 Gene Bradyopsia Test:

  • Delayed visual adaptation when moving between bright and dim environments
  • Difficulty tracking moving objects or perceiving motion accurately
  • Impaired vision in rapidly changing light conditions
  • Family history of inherited retinal disorders or vision problems
  • Unexplained visual processing difficulties despite normal eye examinations
  • Children showing signs of visual processing delays
  • Individuals with suspected inherited phototransduction disorders

Benefits of RGS9 Gene Bradyopsia Testing

Undergoing this comprehensive genetic analysis provides numerous advantages:

  • Accurate Diagnosis: Confirms or rules out RGS9-related bradyopsia with high precision
  • Personalized Management: Enables tailored vision rehabilitation strategies
  • Family Planning Guidance: Provides crucial information for genetic counseling and reproductive decisions
  • Early Intervention: Facilitates proactive management of visual symptoms
  • Differential Diagnosis: Helps distinguish bradyopsia from other retinal disorders
  • Research Contribution: Advances understanding of rare retinal conditions

Understanding Your Test Results

Interpretation Guidance

Your RGS9 Gene Bradyopsia Test results will be carefully interpreted by our genetic specialists:

  • Positive Result: Indicates the presence of pathogenic RGS9 mutations confirming bradyopsia diagnosis
  • Negative Result: Suggests RGS9 mutations are not the cause of symptoms, requiring further evaluation
  • Variant of Uncertain Significance: Identifies genetic changes requiring additional clinical correlation
  • Carrier Status: Determines if you carry a single copy of mutated RGS9 gene

All results include comprehensive genetic counseling to help you understand implications and next steps.

Test Details and Pricing

Test Feature Details
Test Name RGS9 Gene Bradyopsia NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology
Specialty Ophthalmology Genetics

Pre-Test Requirements

Before undergoing the RGS9 Gene Bradyopsia Test, patients should provide:

  • Complete clinical history including visual symptoms and progression
  • Detailed family medical history with emphasis on vision disorders
  • Participation in genetic counseling session to create pedigree chart
  • Documentation of previous ophthalmological evaluations

Nationwide Availability and Booking

We have diagnostic centers conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art facilities ensure consistent, high-quality testing standards nationwide.

Take Control of Your Visual Health Today

Don’t let unexplained visual symptoms affect your quality of life. The RGS9 Gene Bradyopsia NGS Genetic DNA Test provides definitive answers about your genetic predisposition to this rare retinal condition. Our expert team of genetic counselors and ophthalmology specialists are ready to guide you through the testing process and help you understand your results.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book the RGS9 Gene Bradyopsia Test. Take the first step toward understanding your visual health and making informed decisions about your care.